S. Wendt

751 total citations
8 papers, 588 citations indexed

About

S. Wendt is a scholar working on Physiology, Epidemiology and Molecular Biology. According to data from OpenAlex, S. Wendt has authored 8 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 3 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in S. Wendt's work include Lysosomal Storage Disorders Research (7 papers), Trypanosoma species research and implications (3 papers) and Child Nutrition and Feeding Issues (2 papers). S. Wendt is often cited by papers focused on Lysosomal Storage Disorders Research (7 papers), Trypanosoma species research and implications (3 papers) and Child Nutrition and Feeding Issues (2 papers). S. Wendt collaborates with scholars based in Germany, United Kingdom and United States. S. Wendt's co-authors include Michael Beck, Uma Ramaswami, Paul Harmatz, Müge Güçsavaş‐Çalıkoğlu, Christine M. Eng, Joseph Muenzer, Alan Kimura, Marwan Shinawi, J. E. Wraith and Suresh Vijayaraghavan and has published in prestigious journals such as Acta Paediatrica, Genetics in Medicine and Molecular Genetics and Metabolism.

In The Last Decade

S. Wendt

8 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Wendt Germany 4 526 281 178 112 91 8 588
Laila Arash Germany 7 565 1.1× 284 1.0× 174 1.0× 93 0.8× 54 0.6× 8 629
Suresh Vijayaraghavan United Kingdom 7 756 1.4× 373 1.3× 264 1.5× 120 1.1× 135 1.5× 11 862
Norberto Guelbert Argentina 16 514 1.0× 216 0.8× 232 1.3× 68 0.6× 68 0.7× 39 651
Ed Wraith United Kingdom 11 718 1.4× 242 0.9× 203 1.1× 110 1.0× 58 0.6× 24 910
Karen Tylee United Kingdom 16 580 1.1× 259 0.9× 158 0.9× 104 0.9× 40 0.4× 45 704
Taiane Alves Vieira Brazil 10 373 0.7× 178 0.6× 152 0.9× 61 0.5× 44 0.5× 19 444
Joanne Mackey United States 12 580 1.1× 186 0.7× 439 2.5× 152 1.4× 91 1.0× 16 781
M. Smith United Kingdom 4 387 0.7× 165 0.6× 166 0.9× 55 0.5× 44 0.5× 5 454
Elke Miebach Germany 13 989 1.9× 521 1.9× 291 1.6× 181 1.6× 84 0.9× 15 1.1k
Alexander Broomfield United Kingdom 14 358 0.7× 124 0.4× 137 0.8× 81 0.7× 56 0.6× 54 613

Countries citing papers authored by S. Wendt

Since Specialization
Citations

This map shows the geographic impact of S. Wendt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Wendt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Wendt more than expected).

Fields of papers citing papers by S. Wendt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Wendt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Wendt. The network helps show where S. Wendt may publish in the future.

Co-authorship network of co-authors of S. Wendt

This figure shows the co-authorship network connecting the top 25 collaborators of S. Wendt. A scholar is included among the top collaborators of S. Wendt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Wendt. S. Wendt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Eng, Christine M., Joseph Muenzer, Ed Wraith, et al.. (2007). 39 Formation of a Lysosomal Disease Testing Network to enhance the delivery of diagnostic services to patients with lysosomal storage disorders. Molecular Genetics and Metabolism. 92(4). 20–20. 1 indexed citations
2.
Eng, Christine M., Joseph Muenzer, Ed Wraith, et al.. (2007). 29 Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome). Molecular Genetics and Metabolism. 92(4). 18–18. 2 indexed citations
3.
Wendt, S., Eugen Mengel, & Martín Beck. (2006). GAUCHER DISEASE AND MISCELLANEOUS. Acta Paediatrica. 95(S451). 139–144. 1 indexed citations
4.
Muenzer, Joseph, J. E. Wraith, Michael Beck, et al.. (2006). A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genetics in Medicine. 8(8). 465–473. 457 indexed citations
5.
Ramaswami, Uma, S. Wendt, Guillem Pintos‐Morell, et al.. (2006). Enzyme replacement therapy with agalsidase alfa in children with Fabry disease. Acta Paediatrica. 96(1). 122–127. 85 indexed citations
6.
Link, Bianca, et al.. (2006). Musculoskeletal manifestations and orthopaedic problems in patients with mucopolysaccharidosis – an overview. Acta Paediatrica. 95(S451). 113–117. 1 indexed citations
7.
Wendt, S., et al.. (2005). Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa. Journal of Inherited Metabolic Disease. 28(5). 787–788. 31 indexed citations
8.
Faude, Frank, S. Wendt, Bernd Biedermann, et al.. (2001). Facilitation of artificial retinal detachment for macular translocation surgery tested in rabbit.. PubMed. 42(6). 1328–37. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026